BioNexus Gene Lab
BGLC
#10332
Rank
ยฃ7.29 M
Marketcap
ยฃ3.09
Share price
-5.08%
Change (1 day)
31.22%
Change (1 year)

Revenue for BioNexus Gene Lab (BGLC)

Revenue in 2025 (TTM): ยฃ7.27 Million

According to BioNexus Gene Lab's latest financial reports the company's current revenue (TTM ) is ยฃ7.16 Million. In 2024 the company made a revenue of ยฃ7.57 Million a decrease over the revenue in the year 2023 that were of ยฃ7.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioNexus Gene Lab from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ7.27 M-3.97%
2024 ยฃ7.57 M-1.18%
2023 ยฃ7.66 M-15.1%
2022 ยฃ9.03 M-8.75%
2021 ยฃ9.89 M-27.55%
2020 ยฃ13.66 M14013.42%
2019 ยฃ0.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA